NEW YORK, Feb 26 – Orchid Biosciences reported Monday a sharp increase in fourth-quarter 2000 revenues to $5.4 million, compared with $547,000 in the corresponding period in 1999, as sales of its products and services rose.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.

NPR reports that government and private insurers are being slow to cover recently approved CAR-T cell therapies.

CNBC reports that there are thousands of genetic tests available for consumers to chose between.

In Nature this week: genomic analysis of ducks, whole-genome doubling among tumor samples, and more.